Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lalilab is a French biotechnology company specializing in the development and commercialization of innovative microfluidic solutions for life science research. The company provides advanced tools for 3D cell culture, organ-on-a-chip applications, and high-throughput drug screening. By leveraging microfluidic technology, Lalilab enables researchers to create more physiologically relevant environments for studying cellular behavior and drug responses. Their products, such as the Lali-Box, are designed to improve the efficiency and accuracy of preclinical drug development and biological research. The company operates as a spin-off from the University of Bordeaux and CNRS, maintaining strong ties to academic innovation. Lalilab's solutions are primarily utilized in oncology, toxicology, and regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lalilab.